Great Point Partners LLC Solid Biosciences Inc. Call Options Transaction History

Great Point Partners LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$4.6 - $10.13 $919,999 - $2.03 Million	-200,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$7.19 - $32.37 $1.44 Million - $6.47 Million	200,000 New	200,000 $1.84 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $35.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.